About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Drug Assessment
›
Top Articles
Journal of Drug Assessment
1.5
(top 11%)
Impact Factor
1.7
(top 11%)
extended IF
41
(top 10%)
H-Index
71
authors
166
papers
3.7K
citations
345
citing journals
747
citing authors
Most Cited Articles of Journal of Drug Assessment
Title
Year
Citations
The National Association of Specialty Pharmacy Abstract Program
2019
78
Variation in health plan specialty drug coverage: an empirical analysis
2019
78
Coupling patient care management operations with technology and data platform to optimize hepatitis C therapy outcomes
2019
78
Determining specialty pharmacy FTEs (full-time equivalents) needed in a clinical practice
2019
78
Real-world assessment of an integrated clinical model on oral hepatitis C therapy at Southern Ohio Medical Center
2019
78
Development of a specialty pharmacy productivity benchmarking model
2019
78
Impact of multidisciplinary patient education sessions on expectations and understanding of new calcitonin gene-related peptide treatments
2019
78
Impact of outpatient specialty pharmacy on medication adherence in post-kidney transplant patients
2019
78
Impact of a high-touch, collaborative, patient-centric, hepatitis C specialty clinical program on completion of glecaprevir/pibrentasvir therapy
2019
78
Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks
2019
78
Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy
2019
78
Medication adherence and graft survival among kidney transplant recipients
2019
78
Medication adherence and graft survival among heart transplant recipients
2019
78
United States health plan cancer concerns in 2019
2019
78
Impact of a specialty pharmacy benefit on rheumatoid arthritis medication adherence and functional status: a continuation study
2019
78
Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients
2019
78
Appropriate prescribing of antiemetics with oral oncolytic therapy: a single center experience
2019
78
Development of a collaborative pharmacy practice agreement to improve efficiency and management of prescribing in a renal transplant clinic
2019
78
Hereditary angioedema C1-inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
2019
78
Clinical impact of pharmacist interventions on improving outcomes in patients receiving immune globulin therapy in a home setting
2019
78
Development of a palivizumab specialty pharmacy management program
2019
78
Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
2019
78
Cost of leukopenia and neutropenia in metastatic breast cancer within last 12, 36, and 60 months using a curated disease model
2019
78
Integrating high touch specialty pharmacy services within a neurology clinic to improve medication access and affordability
2019
78
Implementation of an internal check of oral oncolytics: a single-center, specialty pharmacy safety initiative
2019
78
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.